DailyEdge
Join 250,000+ Subscribers
And get our 5 minute daily newsletter on what's moving the markets.
*By subscribing to the DailyEdge newsletter, you agree to the terms of the Privacy Policy of the TradeZero broker dealer in your jurisdiction.
Past Editions
Broadcom Starts Amassing $60 Billion to Fund Chips for Anthropic
Broadcom Inc.’s Wall Street syndicate is preparing to raise $60 billion in fresh AI chip financing to support Anthropic PBC and other companies, according to people familiar with the matter.
Banks involved in the debt package are expected to send out syndication letters for a $42 billion Class A senior-secured tranche, the people said, asking not to be identified because the deal has not yet been announced.
Why Is United Therapeutics (UTHR) Stock Rocketing Higher Today?
Shares of biotechnology company United Therapeutics (NASDAQ: UTHR) jumped 13.6% in the afternoon session after a federal district court ruled that competitor Liquidia Corporation infringed patent claims covering United Therapeutics' inhaled treprostinil treatments.
Liquidia Corporation announced in a company press release that the U.S. District Court for the District of Delaware found claims 1 and 14 of U.S. Patent No. 11,826,327 to be valid and infringed by Liquidia's Yutrepia inhalation powder. The court invalidated the other asserted patent claims and ordered both companies, Liquidia and United Therapeutics, to submit proposed legal remedies within one week.
Iovance Biotherapeutics (IOVA) Eyes 60% Revenue Growth, Shares Jump 31%
Iovance Biotherapeutics (NASDAQ: IOVA) saw its share price increase by 31.48 percent on Tuesday, finishing at $14.45 per share after raising its full-year revenue growth guidance by as much as 60 percent, driven by strong demand for its cancer treatments.
In an updated report released the same day, the company said it is now expecting full-year revenues of $410 million to $420 million, up from its previous guidance range of $350 million to $370 million. The new guidance implies an increase of 55.9 percent to 60 percent from the $263 million in revenue reported in 2025.
U.S. Government Selects Navitas to Develop Next-Generation 10 kV SiC Power Semiconductors. Shares Up in Pre-Market
Navitas Semiconductor (Nasdaq: NVTS) announced that it has been awarded the ALATTIS (Accelerated, Large-Area, 10 kV SiC IGBT) program to develop next-generation 10 kV silicon carbide (SiC) power semiconductor technology.
Following a competitive evaluation, the U.S. Army selected Navitas for the program, which will focus on developing and validating a domestic manufacturing process for ultra-high-voltage SiC power semiconductor devices through design, fabrication, and testing.
Dow, S&P 500, Nasdaq Slip as AI Safety Concerns and US-Iran Tensions Resurface
US stock futures turned lower on Monday as US-Iran tensions resurfaced and concerns around AI safety intensified ahead of a busy week of economic data.
Futures tied to the Dow Jones Industrial Average fell 0.3%, S&P 500 futures dropped 0.4%, and Nasdaq-100 futures declined 0.9% after the major indexes posted gains last week.
Markets were unsettled after President Trump rejected Tehran’s proposal to reopen the Strait of Hormuz and end the war. With officials returning to the negotiating table, Trump said talks would resume this week. Brent crude, the international oil benchmark, rose to around $98 per barrel.
Akamai Stock Surges After $12 Billion Anthropic Deal
Akamai Technologies’ stock jumped in pre-market trading on Friday after the company agreed to provide cloud-computing services to Anthropic in a deal valued at $12 billion.
Under the agreement, Anthropic will pay $11.6 billion over seven years to use CPU capacity from Akamai Cloud’s distributed AI infrastructure and software. The companies also have the option to expand the agreement by an additional $9 billion in revenue.
As part of the deal, Anthropic will receive warrants allowing it to purchase up to 5% of Akamai’s outstanding shares at an exercise price of $111.33.